{"transactions":[{"id":1486749,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":90154,"kind":"person","name":"Ballaron Craig","position":1,"cik":"0001779433","reported_name":"Ballaron Craig","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T20:15:12.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 6, 2024 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":8.78,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-015958","document":"form4-06072024_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000141588924015958/form4-06072024_040607.xml","form_type":"4"}},{"id":1858774,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":90154,"kind":"person","name":"Ballaron Craig","position":1,"cik":"0001779433","reported_name":"Ballaron Craig","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T13:05:10.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":10384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 8, 2023 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":10384,"derivative":{"exercise_price":5.7,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":10384},"source":{"system":"sec-edgar","filing":"0001209191-23-036151","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919123036151/doc4.xml","form_type":"4"}},{"id":2234169,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":90154,"kind":"person","name":"Ballaron Craig","position":1,"cik":"0001779433","reported_name":"Ballaron Craig","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T20:20:12.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":10384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 9, 2022 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":10384,"derivative":{"exercise_price":2.15,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":10384},"source":{"system":"sec-edgar","filing":"0001209191-22-036300","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919122036300/doc4.xml","form_type":"4"}},{"id":2663817,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":90154,"kind":"person","name":"Ballaron Craig","position":1,"cik":"0001779433","reported_name":"Ballaron Craig","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T20:33:04.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":8109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment is being file to accurately reflect the true number of options granted."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment is being file to accurately reflect the true number of options granted."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment is being file to accurately reflect the true number of options granted."}],"balance_after":8109,"derivative":{"exercise_price":10.56,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":8109},"source":{"system":"sec-edgar","filing":"0001209191-21-041444","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919121041444/doc4a.xml","form_type":"4/A","original_submission_date":"2021-06-14"}},{"id":2670196,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":90154,"kind":"person","name":"Ballaron Craig","position":1,"cik":"0001779433","reported_name":"Ballaron Craig","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-14T20:59:43.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":5834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":5834,"derivative":{"exercise_price":10.56,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":5834},"source":{"system":"sec-edgar","filing":"0001209191-21-040269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919121040269/doc4.xml","form_type":"4"}},{"id":3046395,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":90154,"kind":"person","name":"Ballaron Craig","position":1,"cik":"0001779433","reported_name":"Ballaron Craig","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-26T20:40:00.000Z","date":"2020-08-25","kind":"purchase","acquired":true,"shares":4772,"price":8.57,"value":40896.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.45 to $8.81 inclusive."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-20-048401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919120048401/doc4.xml","form_type":"4"}},{"id":3046394,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":90154,"kind":"person","name":"Ballaron Craig","position":1,"cik":"0001779433","reported_name":"Ballaron Craig","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-26T20:40:00.000Z","date":"2020-08-24","kind":"purchase","acquired":true,"shares":5228,"price":9.16,"value":47888.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.03 to $9.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2)."}],"balance_after":5228,"source":{"system":"sec-edgar","filing":"0001209191-20-048401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919120048401/doc4.xml","form_type":"4"}},{"id":3111914,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":90154,"kind":"person","name":"Ballaron Craig","position":1,"cik":"0001779433","reported_name":"Ballaron Craig","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option Grant (right to buy)","published_at":"2020-06-12T20:50:02.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":5834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 11, 2020 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":5834,"derivative":{"exercise_price":11.38,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":5834},"source":{"system":"sec-edgar","filing":"0001209191-20-036321","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919120036321/doc4.xml","form_type":"4"}},{"id":3489747,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":90154,"kind":"person","name":"Ballaron Craig","position":1,"cik":"0001779433","reported_name":"Ballaron Craig","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-14T20:52:14.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":17502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the total shares subject to the option shall vest on June 12, 2020 and 1/36th of the total shares subject to the option shall vest monthly thereafter over the remaining two years of the vesting period, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":17502,"derivative":{"exercise_price":9.87,"expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":17502},"source":{"system":"sec-edgar","filing":"0001209191-19-037165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000120919119037165/doc4.xml","form_type":"4"}}]}